Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PTC Therapeutics, Inc. - Common Stock (NQ:PTCT)

66.67 -1.33 (-1.96%)
Streaming Delayed Price Updated: 10:15 AM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PTC Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today? ↗
In its Q3 earnings release, PTC Therapeutics Inc (NASDAQ: PTCT) reported a  
Via Benzinga
News headline image
ALGN Stock Alert: Align Technology Announces $250M Stock Buyback Program ↗
Align Technology stock is rising on Friday after the company announced plans to repurchase $250 million worth of ALGN shares. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Preview: PTC Therapeutics ↗
 
Via Benzinga
News headline image
Expert Ratings for PTC Therapeutics ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 29, 2024 ↗
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Earnings Preview: PTC Therapeutics ↗
 
Via Benzinga
News headline image
1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock? ↗
Bad news for one player does not always equal good news for another. 
Via The Motley Fool
News headline image
PTC Therapeutics Flashes A Bearish Sign After European Officials Reject DMD Drug ↗
European regulators will likely force PTC Therapeutics to pull its drug, Translarna, from the market. 
Via Investor's Business Daily
News headline image
PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe ↗
CHMP issues negative opinion on PTC Therapeutics' Translarna for Duchenne Muscular Dystrophy. CEO expresses disappointment. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Analyst Expectations for PTC Therapeutics's Future ↗
 
Via Benzinga
News headline image
RBLX Stock Alert: Analysts Are Pounding the Table on Roblox ↗
Roblox stock is rising higher on Friday after analysts upgraded shares of RBLX and increased price targets for the gaming company. 
Via InvestorPlace
News headline image
Why Is PTC Therapeutics (PTCT) Stock Down 23% Today? ↗
PTC Therapeutics stock is falling on Friday as PTCT investors react to the company's lackluster earnings report for Q3 2023. 
Via InvestorPlace
News headline image
Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's time to start off the final trading day this week with a breakdown of the biggest pre-market stock movers on Friday! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Why PTC Therapeutics Soared 15% Higher Today ↗
The company scored a $1 billion upfront payment for expanding a commercial partnership. 
Via The Motley Fool
News headline image
Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings ↗
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded down 0.43% to 33,520.17 while the NASDAQ fell 0.75% to 13,214.04. The... 
Via Benzinga
Topics Stocks
News headline image
AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
NASDAQ:PTCT Shareholder Notice: Investigation over Possible Securities Laws Violations by PTC Therapeutics, Inc. ↗
San Diego, CA -- (SBWIRE) -- 10/10/2023 -- PTC Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023 ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 369 companies set new 52-week lows. 
Via Benzinga
News headline image
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday ↗
Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.